Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-08-18

Clinical Trial Update: Creatine Therapy for Huntington's Disease [Phase 1, Phase 2]

View source ↗

Summary

The document reports completion of Phase 1 and Phase 2 evaluations of creatine therapy in Huntington's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Creatine (creatine)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Huntington's Disease | Phase 1, Phase 2 | Status: COMPLETED